Headquartered in Indianapolis, Indiana, Eli Lilly and Company (LLY) is a leading biopharmaceutical firm with a market cap of ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

A slight dip in EPS growth is expected, but sustained strong performance in net income to $32.20 billion and revenue growth ...

A small player like Viking may also win by attracting a partner or even a company that will offer to acquire the biotech.

Even a juggernaut like Eli Lilly ( LLY 2.71%) can miss the mark sometimes. When it reported its third-quarter earnings on Oct. 30, its share price plunged to the tune of 11% before recovering somewhat ...

Eli Lilly (NYSE:LLY) shares snapped six straight sessions of losses on Thursday, as the stock closed 2.7% higher at $797.45.

Technology stocks appear to have shaken off their summertime blues, as the Nasdaq Composite pushes closer to its first record high since July 10, Dow Jones Market Data show. Tech stocks had ...

Novo Nordisk’s net profit of $3.94bn represents a 21% increase from Q3 2023. Net sales in the quarter jumped by the same ...

--Longest losing streak since Aug. 5, 2022, when it fell for six straight trading days --Worst six day stretch since the six days ending March 25, 2020, when it fell 14.85% --Down 19.3% from its ...

AbCellera Biologics ( (ABCL) ) has shared an update. AbCellera reported its Q3 2024 financial results, highlighting a strategic expansion with ...